Navigation Links
Ex-Convicts From Tobacco-Free Prisons Need Help to Stay Off Smokes
Date:4/10/2013

WEDNESDAY, April 10 (HealthDay News) -- Inmates who quit smoking while in smoke-free prisons are more likely to stay tobacco free if they receive special counseling before they're released, new research suggests.

Interventions based on motivational interviewing and behavioral therapy improve smoking cessation rates among ex-convicts, according to a study published April 8 in the journal JAMA Internal Medicine.

The study, led by Dr. Jennifer Clarke, of Memorial Hospital of Rhode Island, involved nearly 300 inmates scheduled for release from a smoke-free prison in roughly eight weeks. Of the participants, 35 percent were women.

Each participant was randomly assigned to receive six weekly sessions of education videos or a behavioral intervention known as the WISE intervention (Working Inside for Smoking Elimination).

Three weeks after they were released from prison, 25 percent of the inmates assigned to the WISE intervention group remained tobacco free. In contrast, only 7 percent of those in the educational video group continued their smoking cessation, according to a journal news release.

The inmates who were smoke-free early on were reassessed at three months. By this point, 12 percent of the inmates from the WISE group and 2 percent of the educational video group remained tobacco-free.

Inmates who were Hispanic, who had a plan to avoid smoking and who had been in prison for more than six months were more likely to succeed in their attempt to stop smoking.

The study received funding from the U.S. National Institutes of Health/National Institute on Drug Abuse.

More information

The U.S. Centers for Disease Control and Prevention has more about tobacco use and smoking.

-- Mary Elizabeth Dallas

SOURCE: JAMA Internal Medicine, news release, April 8, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ex-Convicts From Tobacco-Free Prisons Need Help to Stay Off Smokes
(Date:12/10/2016)... ... December 10, 2016 , ... The ... PATS recently joined forces with other healthcare organizations to promote diabetes education at ... in Harrisburg, featured a variety of speakers from around the Commonwealth of Pennsylvania. ...
(Date:12/9/2016)... , ... December 09, 2016 , ... ... and aural rehabilitation—provided by audiologists—to remain a critical part of public access to ... Drug Administration (FDA) announced this week that, starting immediately, it would ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... miniature, folded, pharmaceutical inserts and outserts. As a means of expanding capabilities ... addition will enable Flottman to individually code professional inserts (PIs) and patient package ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... its 10th anniversary with the grand opening of the Sober College Robert Pfeifer ... spanned two days, December 2-3, and was attended by an overwhelming amount of ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... Ball at The Pierre Hotel in New York, NY, on December 3rd, to ... dignitaries and physicians attended the annual event, which raised over $1 million - ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)...  Eli Lilly and Company (NYSE: LLY ... EXPEDITION3 trial at the 9 th Clinical Trials ... did not meet the primary endpoint in the EXPEDITION3 ... with mild dementia due to Alzheimer,s disease (AD), and ... the treatment of mild dementia due to AD. ...
(Date:12/8/2016)... QUEBEC CITY , Dec. 8, 2016 /PRNewswire/ ... key US patents for improving the accuracy, reproducibility ... CD images in long and small bone orthopaedic ... proprietary approach to creating personalized orthopaedic restorations based ... create personalized orthopaedic restorations, the company harnesses the ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, ... has obtained proof-of-mechanism for neflamapimod (previously code named ... Phase 2a clinical trials that demonstrated significant Alzheimer,s ... 302 (12-week treatment) and Study 303 (6-week treatment) ... Trials in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: